Version history
EndeavorOTC®: Outplay ADHD
24
ASO score
Text
33/100
Reviews
0/100
Graphic
40/100
Other
0/100
App Rating
2.8
Votes
29.35K
App Age
2y 4m
Last Update
Oct 21, 2025
iAP
$15 - 129.99
Compare with Category Top Apps
|
Metrics
|
Current App
|
Category Top Average
|
Difference
|
|---|---|---|---|
|
Installs
|
70.2K
|
2.3M
|
-97%
|
|
Rating
|
3.48
|
4.19
|
-17%
|
|
Number of Ratings (Voted)
|
9.8K
|
2.5M
|
-100%
|
|
App Age
|
2y 3m
|
7y 10m
|
-71%
|
|
In-app Purchases Price
|
$73
|
$45
|
+63
%
|
|
Update Frequency
|
70d
|
149d
|
-53%
|
|
Title Length
|
26
|
26
|
|
|
Short Description Length
|
76
|
64
|
+19%
|
|
Description Length
|
3 348
|
2 668
|
+25%
|
|
Number of Screenshots
|
2088
|
1332
|
+57
%
|
|
Has Video?
|
No
|
0% has videos
|
|
|
Size
|
0MB
|
0MB
|
|
Category Ranking in United States
7 days
Last 7 days
Last 30 days
Last 90 days
Last 180 days
Last year
| Top | Dec 23, 2025 | Dec 30, 2025 |
|---|---|---|
|
29
|
24
|
| Top | Dec 23, 2025 | Dec 30, 2025 |
|---|---|---|
|
No results were found!
|
||
| Top | Dec 23, 2025 | Dec 30, 2025 |
|---|---|---|
|
29
|
24
|
| Top | Dec 23, 2025 | Dec 30, 2025 |
|---|---|---|
|
No results were found!
|
||
Downloads
Downloads Graph
Total
70.1K
Last month
192
Text ASO
Title
(
Characters:
26
of 50
)
EndeavorOTC®: Outplay ADHD
Short Description
(
Characters:
76
of 80
)
The only FDA-authorized digital therapeutic for ADHD without a prescription.
Description
(
Characters:
3348
of 4000
)
Start your subscription today to begin treatment with EndeavorOTC, the game-based ADHD treatment clinically designed to improve symptoms, attention and focus, designed with the same technology as the world’s first FDA-authorized game-based treatment. The treatment includes Focus Score, a first-of-its-kind personalized metric where you can track attention progress.
EndeavorOTC is for adults 18 years and older with ADHD experiencing inattention-related challenges that affect their quality of life such as diminished focus, inability to complete projects or tasks, keep track of important items, and more. Built with the same technology as EndeavorRx, the world's first FDA-authorized video game treatment. EndeavorOTC is available now by subscription. No prescription needed.
EndeavorOTC was studied in more than 220 participants over a 6-week period. In the clinical trial, 88% of participants saw improvement in their attention and 73% of participants reported quality of life improvements, including an increased ability to balance projects, get things done on time and keep track of important items like phone, wallet, and keys. There were no lasting or serious side effects in any clinical trials for EndeavorOTC. (1,2)
How EndeavorOTC improves focus: The gameplay challenges you to tap targets and navigate obstacles to boost your attention and focus. As you progress through the game, the technology is continuously measuring your performance and using adaptive algorithms to adjust the difficulty and personalize the treatment experience.
How to Play EndeavorOTC: Playing EndeavorOTC can fit into your daily routine. The more you play, the better your results.
Playing the game every day for an initial six weeks can improve your attention and other functions that make up your ability to focus. Users will be given a target Focus Score increase which should be achievable in six weeks. Based on clinical trial data, the target increase provided directly relates to improvement in ADHD-related symptoms and overall quality of life. And, for the vast majority of people, this will leave room for continued improvement in Focus Score and cognitive abilities as well as ADHD symptom management beyond the initial six week course of treatment.
It is recommended that patients speak to their health care provider before starting EndeavorOTC treatment, and before making any medical decisions.
© 2025 Akili Interactive Labs, Inc. All Rights Reserved. Akili, EndeavorRx, Endeavor, Akili Care, ADHD Insight, Insight, EndeavorRx Insight, EndeavorOTC, SSME, and Akili Assist, as well as the logos for each, are trademarks or registered trademarks of Akili Interactive Labs, Inc. Other trademarks are trademarks or registered trademarks of their respective owners.
For full instructions for use, please visit https://www.endeavorotc.com/IFU/.
For more information, visit EndeavorOTC.com.
Questions? Email Support@EndeavorOTC.com
Terms of Use: https://my.akili.care/terms
Privacy Notice: https://www.akiliinteractive.com/privacy-notice
1 Stamatis, C. A., Mercaldi, C., & Kollins, S. H., J Am Acad Child Adolesc Psychiatry, 62, S318 (2023). As measured by average percent change in the Test of Variables of Attention-Attention Comparison Score (TOVA-ACS).
2 As measured by the validated Adult ADHD Quality of Life Scale (AAQoL)}
Read more
Other
Additional Information
| Rating: | |
| Voted: | 29.35K |
| Google Play Link: | |
| Website: | |
| Email: | - |
| Privacy Policy: | |
| Categories: | Medical |
| Size: | - |
| iAP: | 15 - 129.99 $ |
| Installs: | 70.06K |
| App Age: | 2 years 4 months |
| Release Date: | Sep 11, 2023 |
| Last Update: | Oct 21, 2025 |
| Version: | 4.0.0 |
Version history
4.0.0
Oct 21, 2025
3.0.2
Jun 26, 2025
Minor technical changes to improve app performance.